ES2530963T3 - Composición farmacéutica que comprende un agente antibacteriano y una sustancia activa seleccionada entre carveol, carvacrol, alfa-ionona, beta-ionona y timol - Google Patents
Composición farmacéutica que comprende un agente antibacteriano y una sustancia activa seleccionada entre carveol, carvacrol, alfa-ionona, beta-ionona y timol Download PDFInfo
- Publication number
- ES2530963T3 ES2530963T3 ES06744753T ES06744753T ES2530963T3 ES 2530963 T3 ES2530963 T3 ES 2530963T3 ES 06744753 T ES06744753 T ES 06744753T ES 06744753 T ES06744753 T ES 06744753T ES 2530963 T3 ES2530963 T3 ES 2530963T3
- Authority
- ES
- Spain
- Prior art keywords
- ionone
- active substance
- carveol
- carvacrol
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composición farmacéutica caracterizada porque comprende: - al menos una primera sustancia terapéuticamente activa, y - al menos una segunda sustancia terapéuticamente activa que es un antibiótico, en la cual: dicha primera sustancia terapéuticamente activa es carveol y el antibiótico se elige entre ampicilina, cloranfenicol, tetraciclina, estreptomicina, eritromicina, polimixina B y amoxicilina; o dicha primera sustancia terapéuticamente activa es carvacrol y el antibiótico se elige entre amoxicilina, amoxicilina asociada a ácido clavulánico y rifampicina; o dicha primera sustancia terapéuticamente activa es alfa-ionona o beta-ionona y el antibiótico es cefazolina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2005/001313 WO2006120494A1 (fr) | 2005-05-13 | 2005-05-13 | Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol |
PCT/IB2006/001350 WO2006120567A2 (fr) | 2005-05-13 | 2006-05-15 | Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2530963T3 true ES2530963T3 (es) | 2015-03-09 |
Family
ID=35427275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES06744753T Active ES2530963T3 (es) | 2005-05-13 | 2006-05-15 | Composición farmacéutica que comprende un agente antibacteriano y una sustancia activa seleccionada entre carveol, carvacrol, alfa-ionona, beta-ionona y timol |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080214518A1 (es) |
EP (1) | EP1879655B1 (es) |
JP (1) | JP5410748B2 (es) |
CN (3) | CN103356612B (es) |
BR (1) | BRPI0610125B8 (es) |
CA (1) | CA2606875C (es) |
DK (1) | DK1879655T3 (es) |
EA (1) | EA014069B1 (es) |
ES (1) | ES2530963T3 (es) |
MA (1) | MA29606B1 (es) |
PT (1) | PT1879655E (es) |
TN (1) | TNSN07424A1 (es) |
WO (2) | WO2006120494A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2918571B1 (fr) * | 2007-07-10 | 2013-01-11 | Aroma Tech | Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales |
DK2214656T3 (en) | 2007-10-26 | 2019-03-25 | Avivagen Inc | COMPOSITIONS AND PROCEDURES TO ENHANCE IMMUNE RESPONSE |
FR2925334A1 (fr) * | 2007-12-21 | 2009-06-26 | Ceva Sante Animale Sa | Nouvelles compositions antibacteriennes |
WO2010124391A1 (en) | 2009-04-30 | 2010-11-04 | Chemaphor Inc. | Methods and compositions for improving the health of animals |
MX2012003563A (es) | 2009-09-24 | 2012-04-30 | Unilever Nv | Agente desinfectante que comprende eugenol, terpineol y timol. |
WO2012076310A1 (en) | 2010-12-07 | 2012-06-14 | Unilever Nv | An oral care composition |
WO2013064360A2 (en) | 2011-11-03 | 2013-05-10 | Unilever N.V. | A personal cleaning composition |
CN104080341B (zh) | 2011-12-06 | 2017-09-22 | 荷兰联合利华有限公司 | 抗微生物组合物 |
CN102670619B (zh) * | 2012-05-08 | 2014-02-19 | 广东药学院 | 一种头孢氨苄冰片组合物 |
CN102670598B (zh) * | 2012-05-08 | 2014-07-16 | 广东药学院 | 一种青霉素冰片组合物在制备抗菌药物中的应用 |
CN103146255B (zh) * | 2013-02-25 | 2014-07-09 | 厦门吉宏包装科技有限公司 | 一种抑菌驱螨印刷底油母液和由母液制作的印刷底油及其制备方法 |
EP2993985A4 (en) * | 2013-05-07 | 2016-10-05 | Kemin Ind Inc | ANTIMICROBIAL COMPOSITIONS WITH CARVACROL AND THYMOL |
FR3025719A1 (fr) | 2014-09-15 | 2016-03-18 | Septeos | Antimicrobiens potentialises |
FR3025718A1 (fr) | 2014-09-15 | 2016-03-18 | Septeos | Antimicrobiens potentialises |
US10780294B2 (en) | 2014-11-19 | 2020-09-22 | The General Hospital Corporation | System and method for photo-dynamic procedure |
JP2017538749A (ja) * | 2014-12-18 | 2017-12-28 | ヘルパービー セラピューティクス リミテッドHelperby Therapeutics Limited | 抗微生物剤の組み合わせおよび微生物感染の治療におけるそれらの使用 |
EP3233105B1 (en) * | 2014-12-18 | 2020-09-30 | Helperby Therapeutics Limited | Novel combination and use |
CN109512998A (zh) * | 2016-03-04 | 2019-03-26 | 广州英赛特生物技术有限公司 | 含氧碳氢衍生物的酯化衍生物作为多粘菌素的协同增效剂的应用 |
FR3048612B1 (fr) | 2016-03-14 | 2020-10-02 | Septeos | Tulathromycine potentialisee |
BR112018074913A2 (pt) | 2016-06-02 | 2019-03-12 | Advanced Scientific Developements | formulação farmacêutica de cineol e amoxicilina |
GB201904963D0 (en) * | 2019-04-08 | 2019-05-22 | Anpario Plc | Composition for reducing antimicrobial resistance |
WO2021110915A1 (fr) | 2019-12-04 | 2021-06-10 | Pranarôm International S.A. | Procede de transformation d'une huile essentielle |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4317775A (en) * | 1980-01-07 | 1982-03-02 | Hoffmann-La Roche Inc. | Amoxicillin derivatives |
DE3634697A1 (de) * | 1986-10-11 | 1988-04-21 | Dentaire Ivoclar Ets | Dentalwerkstoff zur bekaempfung von karies und parodontose |
US5213615A (en) * | 1986-10-11 | 1993-05-25 | Ivoclar Ag | Dental material and method for the control of caries and paradentitis |
US5801153A (en) * | 1991-09-13 | 1998-09-01 | Badaway; Mohammed A. | Method of enhancing the antimicrobial properties of antibacterial antibiotics to massively control and prevent bacterial, fungal, and viral diseases in plants |
FR2697133B1 (fr) * | 1992-10-28 | 1995-01-13 | Transbiotech | Composition biocide et/ou biostatique et ses applications. |
US5308873A (en) * | 1992-12-18 | 1994-05-03 | Doyle E. Chastain | Method of killing yeast and fungi with carveol |
US5916566A (en) * | 1995-06-07 | 1999-06-29 | Avmax, Inc. | Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US6319507B1 (en) * | 1997-05-02 | 2001-11-20 | Kobo Products, Inc. | Agar gel bead composition and method |
US6025400A (en) * | 1998-08-24 | 2000-02-15 | Marco Polo Technologies | Compositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the same |
SE9901733L (sv) * | 1999-05-12 | 2000-11-13 | Akzo Nobel Nv | En komposition innehållande karvakrol och tymol för användning som bactericid |
US6414036B1 (en) * | 1999-09-01 | 2002-07-02 | Van Beek Global/Ninkov Llc | Composition for treatment of infections of humans and animals |
US6495512B1 (en) * | 2000-06-23 | 2002-12-17 | International Flavors & Fragrances Inc. | Salicylaldehyde-containing composition having antimicrobial and fragrancing properties and process for using same |
WO2002028382A1 (en) * | 2000-10-06 | 2002-04-11 | Van Beek, Ron | Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals |
US6787568B1 (en) * | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
US20030064948A1 (en) * | 2001-02-08 | 2003-04-03 | Alfred Fahr | Invasomes for therapy of disorders, their preparation and use |
US6585963B1 (en) * | 2001-02-15 | 2003-07-01 | Watson Pharmaceuticals, Inc. | Nail compositions and methods of administering same |
WO2003049726A1 (en) * | 2001-12-07 | 2003-06-19 | Eden Research Plc | Respiratory infection prevention and treatment with terpene-containing compositions |
US20030225003A1 (en) * | 2002-04-18 | 2003-12-04 | Dusan Ninkov | Antimicrobial therapeutic compositions for oral and topical use |
US20060105000A1 (en) * | 2002-11-21 | 2006-05-18 | J.P.M.E.D. Ltd | Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil |
CN1744905A (zh) * | 2002-12-10 | 2006-03-08 | 百敖新纳斯有限公司 | 局部抗感染制剂 |
US20040151771A1 (en) * | 2003-02-04 | 2004-08-05 | Gin Jerry B. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
SI2338332T1 (sl) * | 2004-05-20 | 2014-06-30 | Eden Research Plc | Votli delec glukana ali votli delec stene celice, ki enkapsulira komponento terpena |
-
2005
- 2005-05-13 WO PCT/IB2005/001313 patent/WO2006120494A1/fr active Application Filing
-
2006
- 2006-05-15 JP JP2008510671A patent/JP5410748B2/ja active Active
- 2006-05-15 DK DK06744753.2T patent/DK1879655T3/en active
- 2006-05-15 CN CN201310230786.1A patent/CN103356612B/zh active Active
- 2006-05-15 CA CA2606875A patent/CA2606875C/fr active Active
- 2006-05-15 CN CN2011101912078A patent/CN102319246B/zh active Active
- 2006-05-15 WO PCT/IB2006/001350 patent/WO2006120567A2/fr active Application Filing
- 2006-05-15 US US11/914,015 patent/US20080214518A1/en not_active Abandoned
- 2006-05-15 ES ES06744753T patent/ES2530963T3/es active Active
- 2006-05-15 EP EP06744753.2A patent/EP1879655B1/fr active Active
- 2006-05-15 EA EA200702483A patent/EA014069B1/ru not_active IP Right Cessation
- 2006-05-15 CN CN2006800164912A patent/CN101175531B/zh active Active
- 2006-05-15 PT PT67447532T patent/PT1879655E/pt unknown
- 2006-05-15 BR BRPI0610125A patent/BRPI0610125B8/pt active IP Right Grant
-
2007
- 2007-11-13 TN TNP2007000424A patent/TNSN07424A1/fr unknown
- 2007-12-28 MA MA30530A patent/MA29606B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EA200702483A1 (ru) | 2008-04-28 |
CN102319246A (zh) | 2012-01-18 |
EP1879655B1 (fr) | 2014-11-26 |
EA014069B1 (ru) | 2010-08-30 |
US20080214518A1 (en) | 2008-09-04 |
CN103356612A (zh) | 2013-10-23 |
BRPI0610125A2 (pt) | 2012-09-25 |
BRPI0610125B1 (pt) | 2020-08-11 |
BRPI0610125B8 (pt) | 2021-05-25 |
EP1879655A2 (fr) | 2008-01-23 |
CN102319246B (zh) | 2013-07-17 |
PT1879655E (pt) | 2015-02-24 |
CA2606875C (fr) | 2015-12-15 |
WO2006120567A3 (fr) | 2007-08-23 |
TNSN07424A1 (fr) | 2009-03-17 |
WO2006120494A1 (fr) | 2006-11-16 |
JP2008540507A (ja) | 2008-11-20 |
WO2006120567A2 (fr) | 2006-11-16 |
DK1879655T3 (en) | 2015-02-23 |
CN103356612B (zh) | 2015-04-15 |
CN101175531B (zh) | 2011-09-07 |
CN101175531A (zh) | 2008-05-07 |
MA29606B1 (fr) | 2008-07-01 |
JP5410748B2 (ja) | 2014-02-05 |
CA2606875A1 (fr) | 2006-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2530963T3 (es) | Composición farmacéutica que comprende un agente antibacteriano y una sustancia activa seleccionada entre carveol, carvacrol, alfa-ionona, beta-ionona y timol | |
ES2497494T3 (es) | Método de tratamiento y prevención del hiperparatiroidismo secundario | |
CL2008002424A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de pirazol-o-glucosido; y uso de la composicion farmaceutica para el tratamiento de la diabetes mellitus, tolerancia anormal a la glucosa e hiperglucemia, trastornos metabolicos, entre otras. | |
ES2500067T3 (es) | Compuesto bicíclico y uso del mismo para fines médicos | |
GT200500246A (es) | Combinacion de compuestos organicos | |
CL2008001821A1 (es) | Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras. | |
CL2008000691A1 (es) | Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades. | |
CR9950A (es) | Composiciones farmaceuticas solidas que contienen pregabalina | |
CL2009002073A1 (es) | Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares. | |
MX290450B (es) | Uso de un copolimero de (met) acrilato anionico, parcialmente neutralizado, como un revestimiento para la produccion de una forma farmaceutica que libera sustancia activa con valores ph reducidos. | |
CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
CL2009000541A1 (es) | Uso de una enzima degradadora de matriz activable (amde) para la formulacion de un medicamento de administracion sub-epidermica; composicion farmacologica y su uso; combinacion que comprende a amde, un activador y un agente; recipiente para amde y para el activador; kit que comprende dicho recipiente | |
CL2008000133A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de pirazol-o-glucosido combinado con al menos un segundo agente terapeutico; y uso de la composicion para el tratamiento de diabetes mellitus, cataratas, neuropatia, infarto de miocardio, e | |
CL2012002521A1 (es) | Composicion farmaceutica que comprende un inhibidor de dpp iv seleccionado de un grupo definido, un primer diluyente, un segundo diluyente: manitol, un segundo diluyente: almidon pregelatinizado, un aglutinante y un lubricante; util en el tratamiento de diabetes. (divisional de la sol. 1260-07). | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
CL2007003429A1 (es) | Tableta bi-capa que comprende una primera capa con al menos un estrogeno y una segunda capa con uno o mas agentes terapeuticos seleccionados entre un modulador selectivo del receptor de estrogeno y un agente progestacional; proceso de produccion, uti | |
CL2011000835A1 (es) | Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras. | |
SV2009003264A (es) | Mejoras en y relacionadas con mecanismos accionadores adecuados para usarse en dispositivos de descarga de farmacos | |
MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
AR059357A1 (es) | Formulaciones farmaceuticas | |
ES2513691T3 (es) | Preparación transdérmica | |
CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
GT200900287A (es) | Extrudidos con enmascaramiento del sabor mejorado | |
AR115913A1 (es) | Formas de dosificación oral biodisponibles, uso, métodos |